|
|
ACADIA Pharmaceuticals Inc.
|
 |
||||||||
|
 |
  |
 |
|
|
||
 |
 |
 
|
return to message board, top of board |
Re: Did you see the price tag?I checked Acadia's website. There are not announcements on an offering. I would think with the cash they have on hand there likely won't be another offering. Acadia mentioned that there are 4,500 diagnosed Rett patients. They also say the following: "Expect the annual average net realized cost of DAYBUE to be ~$375,000." If all diagnosed took the drug you are talking about a max of $1.5 Billion in Revenue. Of course all diagnosed wont' take the drug. Lets assume eventually 1/3rd take the drug and you get revenue of $500 million. Since there is virtually no marketing required as the patients are likely already aware of the drug, uptake on using the drug should be quick. |
||||||||||||
|
|
return to message board, top of board |
| Msg # | Subject | Author | Recs | Date Posted |
| 19657 | Re: Did you see the price tag? | BelieverTim | 3 | 3/15/2023 12:11:07 PM |
| 19661 | Re: Did you see the price tag? | sling5 | 2 | 3/16/2023 10:34:15 AM |
